See up to 3 months of LPCN. The 7-day demo opens the 1M and 3M ranges and puts LPCN on your watchlist.
Start 7-day demoLatest LPCN insider trades
John W. Higuchi - DirectorOpen-market purchase$19K- John W. Higuchi - DirectorOpen-market purchase$36K
About Lipocine Inc. (LPCN)
Lipocine Inc. is an SEC registrant, filing under CIK 0001535955, classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
LPCN Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 3 | 37,568 | $82K |
| Grant or award | 1 | 2,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
LPCN insider transactions (Form 4)
1716 Form 4 filings on record, the earliest from Dec 30, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| John W. Higuchi - Director | Open-market purchase | Common stock | 9,037 | $2.15 | $19K | |
| John W. Higuchi - Director | Open-market purchase | Common stock | 15,970 | $2.23 | $36K | |
| John W. Higuchi - Director | Open-market purchase | Common stock | 12,561 | $2.16 | $27K | |
| Michael Grissinger - Director | Grant or award | Stock Option (Right to Buy) | 2,000 | $2.11 | $4K | |
 Mahesh V. Patel - Officer | Grant or award | Stock Option (Right to Buy) | 52,781 | $2.49 | $131K | |
| John W. Higuchi - Director | Grant or award | Common Stock (Right to Buy) | 1,764 | $2.19 | $4K | |
| Jill M. Jene - Director | Grant or award | Stock Option (Right to Buy) | 1,764 | $2.19 | $4K | |
| Richard Dana Ono - Director | Grant or award | Common Stock (Right to Buy) | 1,764 | $2.19 | $4K | |
| John W. Higuchi - Director | Open-market purchase | Common stock | 40,000 | $2.03 | $81K | |
| John W. Higuchi - Director | Open-market purchase | Common stock | 123,000 | $2.05 | $252K | |
| Mahesh V. Patel - Officer | Open-market purchase | Common stock | 25,000 | $2.03 | $51K | |
| Mahesh V. Patel - Officer | Open-market purchase | Common stock | 25,000 | $2.02 | $51K | |
| Mahesh V. Patel - Officer | Grant or award | Stock Option (Right to Buy) | 25,000 | $8.00 | $200K | |
| Mahesh V. Patel - Officer | Grant or award | Stock Option (Right to Buy) | 8,629 | $4.20 | $36K | |
| Krista Fogarty - Officer | Grant or award | Stock Option (Right to Buy) | 20,786 | $4.20 | $87K | |
| Mahesh V. Patel - Officer | Grant or award | Stock Option (Right to Buy) | 26,691 | $4.80 | $128K | |
| Krista Fogarty - Officer | Grant or award | Stock Option (Right to Buy) | 5,943 | $4.80 | $29K |
LPCN insider trading FAQ
What is the latest insider trade for LPCN?
Lipocine Inc. (LPCN) had 3 insider filings in the last 90 days, with the most recent on 2026-10-02. The full record for LPCN runs to 16 Form 4 filings, the earliest from 2024-12-30. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying LPCN stock?
3 insider purchases of LPCN were filed in the last 90 days, totaling $82K.
How many insiders are selling LPCN stock?
No insider sales of LPCN were filed in the last 90 days.
Where can I see LPCN SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects LPCN Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - John W. Higuchi view on EDGAR
- - John W. Higuchi view on EDGAR
- - Michael Grissinger view on EDGAR
- - Mahesh V. Patel view on EDGAR
- - John W. Higuchi view on EDGAR
- - Jill M. Jene view on EDGAR
- - Richard Dana Ono view on EDGAR
- - John W. Higuchi view on EDGAR
- - John W. Higuchi view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Insider activity in Health Care
- Where LPCN's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow LPCN with a 7-day demo
- LPCN on your watchlist
- Every LPCN Form 4 filing on record
- Up to 3 months of LPCN price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
